Parabilis Medicines, Inc. Proceeds from Sale and Maturity of Marketable Securities
Parabilis Medicines, Inc. (PBLS) reported Proceeds from Sale and Maturity of Marketable Securities of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2026-08-13
- 2026-06-30: Proceeds from Sale and Maturity of Marketable Securities 6 month $0.00.
- 2025-06-30: Proceeds from Sale and Maturity of Marketable Securities 6 month $47.95M.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 6 month |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-13 |
| 2025-06-30 | $47.95M 10-Q · filed 2026-08-13 |